Target intelligence / Profile preview

Ras-related and estrogen-regulated growth inhibitor (RERG)

Target
RERG
Molecular classification
Small GTPase, GTP-binding protein, Ras superfamily
01

Overview

Ras-related and estrogen-regulated growth inhibitor (RERG) is a protein encoded by the RERG gene in humans. It is a member of the Ras superfamily of small GTPases, characterized by GDP/GTP-binding and intrinsic GTPase activity, with higher affinity for GDP than GTP[1][2][8]. RERG acts as a negative regulator of cell proliferation and tumor formation; overexpression in cell lines reduces proliferation rate, colony formation, and tumorigenic potential[1][2][3][8]. Inactivation or loss of RERG expression is associated with breast cancer and may act as a tumor suppressor, particularly in estrogen-regulated contexts[2][3][5]. This protein likely participates in signal transduction pathways that control cell growth in response to estrogen stimulation.

Other names
RAS like estrogen regulated growth inhibitorRas-like estrogen-regulated growth inhibitorRERG
02

Biological functions

Cell proliferation inhibitionTumor suppressionSignal transduction
03

Disease associations

Cancer (notably breast cancer)Tumor formation
04

Biomarkers

Loss of RERG expression (for breast cancer risk or subtype)

Beyond the preview

Go deeper on Ras-related and estrogen-regulated growth inhibitor (RERG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-related and estrogen-regulated growth inhibitor (RERG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call